N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide

C16H20N4O2 — CID 2816322

IUPACN-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide
SMILESCc1cc(NC(=O)CN2CCOCC2)n(-c2ccccc2)n1
InChIInChI=1S/C16H20N4O2/c1-13-11-15(20(18-13)14-5-3-2-4-6-14)17-16(21)12-19-7-9-22-10-8-19/h2-6,11H,7-10,12H2,1H3,(H,17,21)
InChIKeyUYAVDBIZGXONPN-UHFFFAOYSA-N
MW300.36 g/mol
LogP1.45
Rot. Bonds4

About N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide

N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide (PubChem CID 2816322) has the molecular formula C16H20N4O2 and a molecular weight of 300.36 g/mol. Its IUPAC name is N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide.

Molecular Properties

Compound NameN-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide
PubChem CID2816322
Molecular FormulaC16H20N4O2
Molecular Weight300.36 g/mol
Exact Mass300.16
IUPAC NameN-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide
SMILESCc1cc(NC(=O)CN2CCOCC2)n(-c2ccccc2)n1
InChIInChI=1S/C16H20N4O2/c1-13-11-15(20(18-13)14-5-3-2-4-6-14)17-16(21)12-19-7-9-22-10-8-19/h2-6,11H,7-10,12H2,1H3,(H,17,21)
InChIKeyUYAVDBIZGXONPN-UHFFFAOYSA-N
XLogP1.45
TPSA59.39 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500300.36
LogP ≤ 51.45
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(morpholin-4-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide
CID 25069914
N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-{6-[(2-methoxyethyl)(methyl)amino]pyridin-2-yl}pyrimidin-4-yl]acetamide
CID 25074004
Difenamizole
CID 65695
N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(1,4-oxazepan-4-yl)pyridin-2-yl]pyrimidin-4-yl]acetamide
CID 25138089
1-(1-(2-methoxyethyl)-3-(m-tolylamino)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-yl)ethanone
CID 121373220
3-[(5-methyl-2-phenylpyrazol-3-yl)amino]-1H-quinoxalin-2-one
CID 2425419
1-(4-Acetamido-3-methyl-1-phenyl-1H-pyrazol-5-YL)-N-(4-acetamidophenyl)piperidine-4-carboxamide
CID 16030680
3-(7-ethyl-3,4-dimethyl-6-oxo-1-phenylpyrazolo[5,4-b]pyridin-5-yl)-N-(2-morpholin-4-ylethyl)propanamide
CID 20961284
3-[7-ethyl-3,4-dimethyl-1-(3-methylphenyl)-6-oxopyrazolo[5,4-b]pyridin-5-yl]-N-(2-morpholin-4-ylethyl)propanamide
CID 20961352
3,4,7-Trimethyl-5-(3-morpholin-4-yl-3-oxopropyl)-1-phenylpyrazolo[5,4-b]pyridin-6-one
CID 20961546
N-(3-(3-tert-butyl-5-(3-phenylureido)-1H-pyrazol-1-yl)benzyl)-2-(2-oxooxazolidin-3-yl)acetamide
CID 49862493
3-[(2E)-2-[(3-methyl-5-morpholin-4-yl-1-phenylpyrazol-4-yl)methylidene]hydrazinyl]-1H-quinoxalin-2-one
CID 118711236

Frequently Asked Questions

What is the IUPAC name of N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide?
The IUPAC name of N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide (CID 2816322) is N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide.
What is the SMILES notation for N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide?
The canonical SMILES for N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide is Cc1cc(NC(=O)CN2CCOCC2)n(-c2ccccc2)n1.
What is the InChIKey of N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide?
The InChIKey is UYAVDBIZGXONPN-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H20N4O2/c1-13-11-15(20(18-13)14-5-3-2-4-6-14)17-16(21)12-19-7-9-22-10-8-19/h2-6,11H,7-10,12H2,1H3,(H,17,21).
What are the key properties of N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide?
N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide has a molecular weight of 300.36 g/mol, XLogP of 1.45, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-methyl-2-phenylpyrazol-3-yl)-2-morpholin-4-ylacetamide is sourced from PubChem (CID 2816322), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).